Literature DB >> 17403669

Glucose mediates the translocation of NeuroD1 by O-linked glycosylation.

Sreenath S Andrali1, Qingwen Qian, Sabire Ozcan.   

Abstract

O-Linked GlcNAc modification of nuclear and cytosolic proteins has been shown to regulate the function of many cellular proteins. Increased O-linked glycosylation, observed under chronic hyperglycemia conditions, has been implicated in the pathogenesis of diabetes. However, the exact role of O-GlcNAc modification in regulating glucose homeostasis remains to be established. We report here that the subcellular localization of the pancreatic beta cell-specific transcription factor NeuroD1 is regulated by O-linked glycosylation in the mouse insulinoma cell line MIN6. Under low glucose conditions, NeuroD1 is mainly in the cytosol. However, treatment of MIN6 cells with high glucose results in O-linked GlcNAc modification of NeuroD1 and its subsequent translocation into the nucleus. Consistent with these data, treatment of MIN6 cells with O-(2-acetamido-2-deoxy-d-glucopyranosylidene)-amino N-phenylcarbamate, an inhibitor of O-GlcNAcase, causes Neuro-D1 localization to the nucleus and induction of insulin gene expression even on low glucose. Furthermore, we demonstrate that NeuroD1 interacts with the O-GlcNAc transferase, OGT only at high concentrations of glucose and depletion of OGT by using small interfering RNA oligos interferes with the nuclear localization of NeuroD1 on high glucose. On low glucose NeuroD1 interacts with the O-GlcNAcase and becomes deglycosylated, which is likely to be important for export of Neuro-D1 into cytosol in the presence of low glucose. In summary, the presented data suggest that glucose regulates the subcellular localization of NeuroD1 in pancreatic beta cells via O-linked GlcNAc modification of NeuroD1 by OGT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403669      PMCID: PMC2096475          DOI: 10.1074/jbc.M701762200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization.

Authors:  Tony Lefebvre; Stéphanie Ferreira; Laetitia Dupont-Wallois; Thierry Bussière; Marie-Joëlle Dupire; André Delacourte; Jean-Claude Michalski; Marie-Laure Caillet-Boudin
Journal:  Biochim Biophys Acta       Date:  2003-01-20

Review 2.  Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification.

Authors:  Keith Vosseller; Kaoru Sakabe; Lance Wells; Gerald W Hart
Journal:  Curr Opin Chem Biol       Date:  2002-12       Impact factor: 8.822

3.  Glucose induced MAPK signalling influences NeuroD1-mediated activation and nuclear localization.

Authors:  Helle V Petersen; Jan N Jensen; Roland Stein; Palle Serup
Journal:  FEBS Lett       Date:  2002-09-25       Impact factor: 4.124

4.  Glucose regulates insulin gene transcription by hyperacetylation of histone h4.

Authors:  Amber L Mosley; Sabire Ozcan
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

Review 5.  Hexosamines as mediators of nutrient sensing and regulation in diabetes.

Authors:  Donald A McClain
Journal:  J Diabetes Complications       Date:  2002 Jan-Feb       Impact factor: 2.852

6.  Differential expression of insulin genes 1 and 2 in MIN6 cells and pseudoislets.

Authors:  Helen Roderigo-Milne; Astrid C Hauge-Evans; Shanta J Persaud; Peter M Jones
Journal:  Biochem Biophys Res Commun       Date:  2002-08-23       Impact factor: 3.575

7.  Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia.

Authors:  Donald A McClain; William A Lubas; Robert C Cooksey; Mark Hazel; Glendon J Parker; Dona C Love; John A Hanover
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

Review 8.  Transgenic mice overexpressing the rate-limiting enzyme for hexosamine synthesis in skeletal muscle or adipose tissue exhibit total body insulin resistance.

Authors:  Robert C Cooksey; Donald A McClain
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

9.  MafA is a glucose-regulated and pancreatic beta-cell-specific transcriptional activator for the insulin gene.

Authors:  Kohsuke Kataoka; Song-iee Han; Setsuko Shioda; Momoki Hirai; Makoto Nishizawa; Hiroshi Handa
Journal:  J Biol Chem       Date:  2002-10-03       Impact factor: 5.157

10.  Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression.

Authors:  Xiaoyong Yang; Fengxue Zhang; Jeffrey E Kudlow
Journal:  Cell       Date:  2002-07-12       Impact factor: 41.582

View more
  55 in total

1.  Blocking O-linked GlcNAc cycling in Drosophila insulin-producing cells perturbs glucose-insulin homeostasis.

Authors:  Osamu Sekine; Dona C Love; David S Rubenstein; John A Hanover
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  Glucose activates free fatty acid receptor 1 gene transcription via phosphatidylinositol-3-kinase-dependent O-GlcNAcylation of pancreas-duodenum homeobox-1.

Authors:  Melkam Kebede; Mourad Ferdaoussi; Arturo Mancini; Thierry Alquier; Rohit N Kulkarni; Michael D Walker; Vincent Poitout
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 3.  Protein O-GlcNAcylation in diabetes and diabetic complications.

Authors:  Junfeng Ma; Gerald W Hart
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

4.  Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription.

Authors:  Xiaoqing Tang; Latha Muniappan; Guiliang Tang; Sabire Ozcan
Journal:  RNA       Date:  2008-12-18       Impact factor: 4.942

5.  Dynamic glucose enhanced MRI of the placenta in a mouse model of intrauterine inflammation.

Authors:  Dan Wu; Jiadi Xu; Jun Lei; Michael Mclane; Peter C van Zijl; Irina Burd
Journal:  Placenta       Date:  2018-07-20       Impact factor: 3.481

6.  The hexosamine biosynthesis pathway is essential for pancreatic beta cell development.

Authors:  Gaëlle Filhoulaud; Ghislaine Guillemain; Raphaël Scharfmann
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

Review 7.  Modulation of transcription factor function by O-GlcNAc modification.

Authors:  Sabire Ozcan; Sreenath S Andrali; Jamie E L Cantrell
Journal:  Biochim Biophys Acta       Date:  2010-03-02

8.  The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression.

Authors:  Sandii Brimble; Edith E Wollaston-Hayden; Chin Fen Teo; Andrew C Morris; Lance Wells
Journal:  Curr Signal Transduct Ther       Date:  2010

9.  O-GlcNAc protein modification in cancer cells increases in response to glucose deprivation through glycogen degradation.

Authors:  Jeong Gu Kang; Sang Yoon Park; Suena Ji; Insook Jang; Sujin Park; Hyun Sil Kim; Sung-Min Kim; Jong In Yook; Yong-Il Park; Jürgen Roth; Jin Won Cho
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

10.  Elevation of Global O-GlcNAc in rodents using a selective O-GlcNAcase inhibitor does not cause insulin resistance or perturb glucohomeostasis.

Authors:  Matthew S Macauley; Xiaoyang Shan; Scott A Yuzwa; Tracey M Gloster; David J Vocadlo
Journal:  Chem Biol       Date:  2010-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.